Clinical Trial Update: Adjuvant CCRT vs CT in Minimal N2 NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial comparing adjuvant concurrent chemoradiotherapy to chemotherapy in minimal N2 non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Samsung Medical Center | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED